Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
Active, not recruiting · NCT07223983 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS) | Alcohol Use Disorder, Body Weight, Body Weight Changes, Chemically-Induced Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, alcohol-related disorders, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 1 | 2026-09-10 | NCT07223983 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yale University | 458 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Yale School of Medicine | New Haven | United States | 17 |